Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specifying the patterns of immune cell migration.

Jason G Cyster1

  • 1Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, CA 94143, USA.

Novartis Foundation Symposium
|May 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal intraepithelial lymphocyte migration and tissue homeostasis are dictated by Gα13.

bioRxiv : the preprint server for biology·2026
Same author

ABCC1 protects skin dendritic cells from FITC-induced toxicity by efflux and extracellular glutathione buffering.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine.

The Journal of experimental medicine·2025
Same author

In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.

bioRxiv : the preprint server for biology·2025
Same author

Author Correction: EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells.

Nature·2025
Same author

Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8.

Cell genomics·2025
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Immune cell migration is crucial for health and disease. New research highlights CD69

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Immune system function relies on precise immune cell trafficking.
  • Chemokines are key guidance factors for immune cell recruitment and positioning.
  • Lymphocyte migration within lymphoid organs and egress are critical for immune surveillance and response.

Purpose of the Study:

  • To summarize the role of chemokines in organizing lymphoid tissues.
  • To discuss the molecular mechanisms regulating lymphocyte egress from lymphoid organs.
  • To highlight the recent identification of CD69 as a controller of lymphocyte egress.

Main Methods:

  • Utilizing two-photon imaging of intact lymphoid organs to observe lymphocyte chemotaxis.
  • Investigating the function of sphingosine-1-phosphate (S1P) receptor 1 and its ligand S1P in lymphocyte egress.

Related Experiment Videos

  • Identifying and characterizing the role of CD69 in regulating S1P receptor 1 and lymphocyte egress.

    • Main Results:

    • Chemokines are essential organizers of lymphoid tissues, guiding immune cell positioning.
    • Lymphocyte egress from lymphoid organs requires sphingosine-1-phosphate (S1P) receptor 1 and S1P.
    • CD69 has been identified as a novel regulator of S1P receptor 1, controlling lymphocyte egress.

    Conclusions:

    • Understanding lymphocyte egress is vital for addressing immunological diseases.
    • CD69 emerges as a critical molecular player in controlling lymphocyte exit from lymphoid organs.
    • Further molecular insights into lymphocyte egress can inform therapeutic strategies for immune disorders.